198 related articles for article (PubMed ID: 22649727)
1. TRIM22: A Diverse and Dynamic Antiviral Protein.
Hattlmann CJ; Kelly JN; Barr SD
Mol Biol Int; 2012; 2012():153415. PubMed ID: 22649727
[TBL] [Abstract][Full Text] [Related]
2. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain.
Gao B; Duan Z; Xu W; Xiong S
Hepatology; 2009 Aug; 50(2):424-33. PubMed ID: 19585648
[TBL] [Abstract][Full Text] [Related]
3. Ancient and recent adaptive evolution in the antiviral TRIM22 gene: identification of a single-nucleotide polymorphism that impacts TRIM22 function.
Kelly JN; Woods MW; Xhiku S; Barr SD
Hum Mutat; 2014 Sep; 35(9):1072-81. PubMed ID: 24863734
[TBL] [Abstract][Full Text] [Related]
4. Nuclear localization signal in TRIM22 is essential for inhibition of type 2 porcine reproductive and respiratory syndrome virus replication in MARC-145 cells.
Jing H; Tao R; Dong N; Cao S; Sun Y; Ke W; Li Y; Wang J; Zhang Y; Huang H; Dong W
Virus Genes; 2019 Oct; 55(5):660-672. PubMed ID: 31375995
[TBL] [Abstract][Full Text] [Related]
5. Tripartite Motif 22 (TRIM22) protein restricts herpes simplex virus 1 by epigenetic silencing of viral immediate-early genes.
Reddi TS; Merkl PE; Lim SY; Letvin NL; Knipe DM
PLoS Pathog; 2021 Feb; 17(2):e1009281. PubMed ID: 33524065
[TBL] [Abstract][Full Text] [Related]
6. In silico analysis of functional single nucleotide polymorphisms in the human TRIM22 gene.
Kelly JN; Barr SD
PLoS One; 2014; 9(7):e101436. PubMed ID: 24983760
[TBL] [Abstract][Full Text] [Related]
7. TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus.
Eldin P; Papon L; Oteiza A; Brocchi E; Lawson TG; Mechti N
J Gen Virol; 2009 Mar; 90(Pt 3):536-545. PubMed ID: 19218198
[TBL] [Abstract][Full Text] [Related]
8. Expression of TRIM22 mRNA in chronic hepatitis C patients treated with direct-acting antiviral drugs.
Naveed M; Ali A; Sheikh N; Rafique S; Idrees M
APMIS; 2020 Apr; 128(4):326-334. PubMed ID: 31863490
[TBL] [Abstract][Full Text] [Related]
9. The interferon response inhibits HIV particle production by induction of TRIM22.
Barr SD; Smiley JR; Bushman FD
PLoS Pathog; 2008 Feb; 4(2):e1000007. PubMed ID: 18389079
[TBL] [Abstract][Full Text] [Related]
10. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection.
Singh R; Gaiha G; Werner L; McKim K; Mlisana K; Luban J; Walker BD; Karim SS; Brass AL; Ndung'u T;
J Virol; 2011 Jan; 85(1):208-16. PubMed ID: 20980524
[TBL] [Abstract][Full Text] [Related]
11. The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infection.
Vicenzi E; Poli G
Cytokine Growth Factor Rev; 2018 Apr; 40():40-47. PubMed ID: 29650252
[TBL] [Abstract][Full Text] [Related]
12. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals.
Sawyer SL; Emerman M; Malik HS
PLoS Pathog; 2007 Dec; 3(12):e197. PubMed ID: 18159944
[TBL] [Abstract][Full Text] [Related]
13. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.
Kajaste-Rudnitski A; Marelli SS; Pultrone C; Pertel T; Uchil PD; Mechti N; Mothes W; Poli G; Luban J; Vicenzi E
J Virol; 2011 May; 85(10):5183-96. PubMed ID: 21345949
[TBL] [Abstract][Full Text] [Related]
14. Evolution-Guided Structural and Functional Analyses of the HERC Family Reveal an Ancient Marine Origin and Determinants of Antiviral Activity.
Paparisto E; Woods MW; Coleman MD; Moghadasi SA; Kochar DS; Tom SK; Kohio HP; Gibson RM; Rohringer TJ; Hunt NR; Di Gravio EJ; Zhang JY; Tian M; Gao Y; Arts EJ; Barr SD
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669830
[TBL] [Abstract][Full Text] [Related]
15. Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1.
Forlani G; Tosi G; Turrini F; Poli G; Vicenzi E; Accolla RS
Front Immunol; 2017; 8():564. PubMed ID: 28555140
[TBL] [Abstract][Full Text] [Related]
16. A 5' extended IFN-stimulating response element is crucial for IFN-gamma-induced tripartite motif 22 expression via interaction with IFN regulatory factor-1.
Gao B; Wang Y; Xu W; Duan Z; Xiong S
J Immunol; 2010 Aug; 185(4):2314-23. PubMed ID: 20631312
[TBL] [Abstract][Full Text] [Related]
17. Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease.
Ghezzi S; Galli L; Kajaste-Rudnitski A; Turrini F; Marelli S; Toniolo D; Casoli C; Riva A; Poli G; Castagna A; Vicenzi E
AIDS; 2013 Sep; 27(15):2335-44. PubMed ID: 23921607
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of TRIM5 and TRIM22 polymorphisms on treatment responses in Iranian patients with chronic hepatitis C virus infection.
Mobasheri S; Irani N; Sepahi AA; Sakhaee F; Jamnani FR; Vaziri F; Siadat SD; Fateh A
Gene; 2018 Nov; 676():95-100. PubMed ID: 30017737
[TBL] [Abstract][Full Text] [Related]
19. Mutations Conferring Increased Sensitivity to Tripartite Motif 22 Restriction Accumulated Progressively in the Nucleoprotein of Seasonal Influenza A (H1N1) Viruses between 1918 and 2009.
Pagani I; Di Pietro A; Oteiza A; Ghitti M; Mechti N; Naffakh N; Vicenzi E
mSphere; 2018 Apr; 3(2):. PubMed ID: 29624498
[TBL] [Abstract][Full Text] [Related]
20. Dynamic localization of tripartite motif-containing 22 in nuclear and nucleolar bodies.
Sivaramakrishnan G; Sun Y; Tan SK; Lin VC
Exp Cell Res; 2009 May; 315(8):1521-32. PubMed ID: 19331816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
